ARTICLE | Company News
4SC, Serono autoimmune deal
May 4, 2004 7:00 AM UTC
Serono (SWX:SEO; SRA) licensed exclusive global rights from 4SC (Martinsried, Germany) to develop and commercialize 4SC's dihydroorotate dehydrogenase (DHODH) inhibitors. The deal includes 4SC's lead ...